EP2094665A4 - Préparation de montélukast et de ses sels - Google Patents

Préparation de montélukast et de ses sels

Info

Publication number
EP2094665A4
EP2094665A4 EP07844907A EP07844907A EP2094665A4 EP 2094665 A4 EP2094665 A4 EP 2094665A4 EP 07844907 A EP07844907 A EP 07844907A EP 07844907 A EP07844907 A EP 07844907A EP 2094665 A4 EP2094665 A4 EP 2094665A4
Authority
EP
European Patent Office
Prior art keywords
montelukast
salts
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07844907A
Other languages
German (de)
English (en)
Other versions
EP2094665A2 (fr
Inventor
Pratap Reddy Padi
Satyanarayana Bollikonda
Narsimha Naidu
Debasish Ghosh
Kandirelli Kiran Kumar Venkata
Rajender Reddy Jinna
Ravi Kumar Kasturi
Saravanan Mohanarangam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Original Assignee
Dr Reddys Laboratories Ltd
Dr Reddys Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Laboratories Ltd, Dr Reddys Laboratories Inc filed Critical Dr Reddys Laboratories Ltd
Publication of EP2094665A2 publication Critical patent/EP2094665A2/fr
Publication of EP2094665A4 publication Critical patent/EP2094665A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
EP07844907A 2006-11-06 2007-11-06 Préparation de montélukast et de ses sels Withdrawn EP2094665A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
IN2042CH2006 2006-11-06
IN142CH2007 2007-01-22
US89021507P 2007-02-16 2007-02-16
US91486207P 2007-04-30 2007-04-30
PCT/US2007/083756 WO2008058118A2 (fr) 2006-11-06 2007-11-06 Préparation de montélukast et de ses sels

Publications (2)

Publication Number Publication Date
EP2094665A2 EP2094665A2 (fr) 2009-09-02
EP2094665A4 true EP2094665A4 (fr) 2010-11-24

Family

ID=39365306

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07844907A Withdrawn EP2094665A4 (fr) 2006-11-06 2007-11-06 Préparation de montélukast et de ses sels

Country Status (2)

Country Link
EP (1) EP2094665A4 (fr)
WO (1) WO2008058118A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101213177A (zh) 2005-07-05 2008-07-02 特瓦制药工业有限公司 孟鲁司特的纯化
WO2008035379A2 (fr) * 2006-09-19 2008-03-27 Aptuit Laurus Private Limited Procédé de production d'antagonistes de leucotriène et produits intermédiaires correspondants
EP2552892A1 (fr) 2010-03-31 2013-02-06 KRKA, D.D., Novo Mesto Synthèse efficace pour la préparation de montélukast et nouvelle forme cristalline d'intermédiaires dans celle-ci
CN102702097A (zh) * 2012-05-16 2012-10-03 浙江大学 一种孟鲁司特钠中间体的制备方法
CN104109122B (zh) * 2013-04-16 2017-03-29 浙江奥翔药业股份有限公司 用于合成孟鲁司特的中间体化合物及其制备方法
CN103288695B (zh) * 2013-06-18 2016-01-13 成都迈斯克医药科技有限公司 1-巯甲基环丙基乙酸的制备方法
CN103554016B (zh) * 2013-08-23 2015-09-23 南通正达农化有限公司 一种非激素抗炎药中间体的加工工艺
CN103554017B (zh) * 2013-10-25 2014-12-17 河北序能生物技术有限公司 一种孟鲁司特钠手性中间体的制备方法
WO2015163978A1 (fr) 2014-04-25 2015-10-29 R.P. Scherer Technologies, Llc Solution stable de montélukast
CN104592110A (zh) * 2015-01-26 2015-05-06 中山奕安泰医药科技有限公司 一种合成2-[3-(s)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羟基丙基]苯甲酸甲酯的工艺
CN109020830A (zh) * 2018-08-29 2018-12-18 广州康瑞泰药业有限公司 一种羟甲基环丙基乙腈衍生物及其制备和应用方法
CN114702416A (zh) * 2022-03-30 2022-07-05 法姆瑞斯医药科技(北京)有限公司 一种高效制备孟鲁司特钠侧链中间体的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018107A1 (fr) * 1993-12-28 1995-07-06 Merck & Co., Inc. Procede de preparation d'antagonistes des leukotrienes
US20050234241A1 (en) * 2004-04-15 2005-10-20 Venkataraman Sundaram Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (montelukast) and its pharmaceutically acceptable salts
WO2006021974A1 (fr) * 2004-08-23 2006-03-02 Morepen Laboratories Limited Procede pour synthetiser un diol (viii), intermediaire du sodium de montelukast

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565473A (en) * 1990-10-12 1996-10-15 Merck Frosst Canada, Inc. Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
US5869673A (en) * 1997-02-28 1999-02-09 Merck & Co., Inc. Process for 3-(2-(7-chloro-2-quinolinyl)ethenyl) - benzaldehyde
DE19963115B4 (de) * 1999-12-24 2009-04-09 Evonik Degussa Gmbh Verfahren zur Herstellung von Cyclopropan-1,1-dicarbonsäurediestern

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018107A1 (fr) * 1993-12-28 1995-07-06 Merck & Co., Inc. Procede de preparation d'antagonistes des leukotrienes
US20050234241A1 (en) * 2004-04-15 2005-10-20 Venkataraman Sundaram Process for the preparation of [R-(E)-1-[[[1-[3-[2-[7-chloro-2-quinolinyl]ethenyl]phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]thio]methyl]cyclopropaneacetic acid (montelukast) and its pharmaceutically acceptable salts
WO2006021974A1 (fr) * 2004-08-23 2006-03-02 Morepen Laboratories Limited Procede pour synthetiser un diol (viii), intermediaire du sodium de montelukast

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SASSIAN ET AL: "Solvation Effects in the Grignard Reacion with Carbonyl Compounds", HELVETICA CHIMICA ACTA,, vol. 86, 1 January 2003 (2003-01-01), pages 82 - 90, XP008109226 *

Also Published As

Publication number Publication date
WO2008058118A2 (fr) 2008-05-15
EP2094665A2 (fr) 2009-09-02
WO2008058118A3 (fr) 2008-07-10

Similar Documents

Publication Publication Date Title
HK1254895A1 (zh) 苄基苯衍生物及使用方法
EP2094665A4 (fr) Préparation de montélukast et de ses sels
IL198397A0 (en) Anilinopiperazine derivatives and methods of use thereof
EP2021455A4 (fr) Système de préparation de cytoblocs et procédés d'utilisation associés
IL196956A0 (en) Aza-benzofuranyl compounds and methods of use
SI1981859T1 (sl) Pripravek delmopinola
HK1147254A1 (en) 5-anilinoimidazopyridines and methods of use 5-
EP2023718A4 (fr) Composés de ligand de créatine et procédés d'utilisation correspondants
ZA200902393B (en) Preparation of azoxystrobin
HK1144319A1 (en) Compositions and methods of detecting tiabs
ZA200808017B (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
IL197060A0 (en) Aza-benzothiophenyl compounds and methods of use
ZA201106299B (en) Composition comprising caftaric acid and/or derivatives thereof
IL206125A0 (en) Azaindolizines and methods of use
EP1912499A4 (fr) Preparation de montelukast
EP2265586A4 (fr) Préparation de montélukast et ses sels
ZA200903401B (en) The uses of the carboxy-amido-triazole compounds and salts thereof
IL196594A0 (en) Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors
HK1139153A1 (en) Quinolone compound and pharmaceutical composition
HK1135972A1 (en) 4-substituted azaadamantane derivatives and methods of use thereof 4-
EP2069307A4 (fr) Procédé pour la préparation de montelukast et de ses sels
IL192700A0 (en) Use of elderberry extract
IL196320A0 (en) Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones
ZA200900896B (en) Aza-benzofuranyl compounds and methods of use
IL192552A0 (en) Dnt-succinate and methods of preparation thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090604

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20101027

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 323/26 20060101ALI20101021BHEP

Ipc: A61K 31/47 20060101ALI20101021BHEP

Ipc: A01N 43/42 20060101ALI20101021BHEP

Ipc: C07D 215/18 20060101AFI20090629BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110526